Skip to main content

What the FDA labels say about taking them together

Levothyroxine and thyroid

Thyroid's FDA label of November 15, 2023 names levothyroxine in its drug interactions (prescription label) section; the levothyroxine labels PlainMeds reads (4) do not name thyroid. The thyroid label: “In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free levothyroxine may be decreased when estrogens are started thus increasing thyroid requirements.”

Check it at the source: the levothyroxine FDA label on DailyMed (effective February 20, 2024, AbbVie Inc.); the thyroid FDA label on DailyMed (effective November 15, 2023).

What does the levothyroxine label say about thyroid?

Levothyroxine's label (effective February 20, 2024) and its 3 other brand-application labels do not name thyroid in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Synthroid), AbbVie Inc., effective February 20, 2024 (SPL set 1e11ad30-1041-4520-10b0-8f9d30d30fcc), via openFDA; the full label on DailyMed

What does the thyroid label say about levothyroxine?

Thyroid label, drug interactions (prescription label)

In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free levothyroxine may be decreased when estrogens are started thus increasing thyroid requirements.

Source: FDA drug label (Thyroidinum), Boiron, effective November 15, 2023 (SPL set 86335e4b-a2f8-6143-e053-2a91aa0a29c6), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

36Levothyroxine generic labelers
0Thyroid generic labelers
LevothyroxineThyroid
Labeled forHypothyroidismn/a
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0588 per tablet 112 mcg tablet$1.20 per tablet 120 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?